Our findings align with recent studies suggesting that hippocampal volume loss may be independent of tau‐driven mechanisms, and reflect a combination of neuronal loss, amyloid‐induced synaptic dysfunction and other pathophysiological processes, including neuroinflammation and vascular factors [57, 58]. The gene discussed is MAPT; the disease is amyloidosis.